Journey Medical (DERM) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 0.3.
- Journey Medical's Equity Ratio rose 7819.26% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year increase of 7819.26%. This contributed to the annual value of 0.25 for FY2024, which is 554.97% down from last year.
- Journey Medical's Equity Ratio amounted to 0.3 in Q3 2025, which was up 7819.26% from 0.24 recorded in Q2 2025.
- Journey Medical's 5-year Equity Ratio high stood at 0.43 for Q4 2021, and its period low was 0.13 during Q3 2021.
- In the last 5 years, Journey Medical's Equity Ratio had a median value of 0.24 in 2022 and averaged 0.21.
- As far as peak fluctuations go, Journey Medical's Equity Ratio plummeted by 9997.66% in 2023, and later surged by 24159487.64% in 2024.
- Over the past 5 years, Journey Medical's Equity Ratio (Quarter) stood at 0.43 in 2021, then tumbled by 62.63% to 0.16 in 2022, then surged by 63.98% to 0.26 in 2023, then dropped by 5.55% to 0.25 in 2024, then increased by 21.55% to 0.3 in 2025.
- Its last three reported values are 0.3 in Q3 2025, 0.24 for Q2 2025, and 0.25 during Q1 2025.